Novartis | NVS - Операционные расходы

Биржевая цена
146.79
Изменение за день
-1.19 -0.80%
Ежемесячно
-4.65%
Ежегодный
28.39%
Q2 прогноз
142.62




Операционные расходы Изменить Дата
AbbVie USD 10.27B 538M 2026-03
Amgen USD 4.78B 1.12B 2026-03
AstraZeneca USD 8.18B 4.35B 2026-03
Bausch Health Companies USD 2.04B 42M 2026-03
Biogen USD 1.96B 69.6M 2026-03
Bristol-Myers Squibb USD 20.07B 11.77B 2026-03
Canopy Growth CAD 87.2M 6.22M 2025-12
Corcept Therapeutics USD 214.5M 16.87M 2026-03
Drreddys Laboratories INR 72.94B 4.33B 2025-12
Eli Lilly USD 10.02B 285M 2026-03
Gilead Sciences USD 4.96B 707M 2025-12
GlaxoSmithKline GBP 5.34B 1.85B 2026-03
Glaxosmithkline GBP 9.17B 1.4B 2025-12
J&J USD 17.44B 1.53B 2026-03
Merck USD 18.17B 8.01B 2026-03
Novartis USD 9.8B 61M 2025-12
Novartis USD 9.8B 23M 2025-12
Pacira USD 172.75M 20.93M 2026-03
Perrigo USD 1.03B 75.3M 2025-12
Pfizer USD 12.91B 79.89B 2025-12
Phibro Animal Health USD 332.36M 20.68M 2025-12
Prestige Brands USD 200.95M 6.51M 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 9.31B 1.2B 2026-03
Sanofi EUR 10.71B 1.32B 2025-12
Supernus Pharmaceuticals USD 197.75M 54.54M 2025-12
Zoetis USD 1.55B 3.85B 2025-12